1
|
Savas HB, Gunizi H. Thiol-disulfide balance and trace element levels in patients with seasonal allergic rhinitis. Afr Health Sci 2022; 22:322-328. [PMID: 36910410 PMCID: PMC9993264 DOI: 10.4314/ahs.v22i3.34] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Background The prevalence of allergic diseases is gradually increasing worldwide. The most common such allergic disease is allergic rhinitis (AR). Objective The present study investigated the possible relationship between seasonal AR and the thiol-disulfide balance and zinc and copper levels in adult individuals. Study Design and Methods 130 male and female adults were included in the study. The participants' serum thiol-disulfide balance and zinc and copper levels were measured spectrophotometrically using commercial kits. Statistical significance was accepted as p < 0.05 between the groups. Results The serum copper (p = 0.001), native thiol (p = 0.006), reduced thiol (p < 0.001), and thiol oxidation reduction ratio (p < 0.001) levels were significantly lower in the seasonal AR group than in the control group. Conclusion In AR patients, the low level of copper, which is an important trace element, the deterioration of the thiol-disulfide balance, which represents a unique indicator of the oxidant-antioxidant balance, the increased disulfide level caused by oxidative stress, and the decreased native thiol level can all serve as important biochemical markers.
Collapse
Affiliation(s)
- Hasan Basri Savas
- Mardin Artuklu University, Faculty of Medicine, Department of Medical Biochemistry, Mardin, Turkey. Orcid: orcid.org/0000-0001-8759-4507
| | - Huseyin Gunizi
- Alanya Keykubat University, Faculty of Medicine, Department of Ear Nose and Throat, Alanya, Antalya, Turkey. Orcid: orcid.org/0000-0001-8653-0544
| |
Collapse
|
2
|
Baiardini I, Paoletti G, Mariani A, Malvezzi L, Pirola F, Spriano G, Mercante G, Puggioni F, Racca F, Melone G, Malipiero G, Ferri S, Canonica GW, Heffler E. Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps. Healthcare (Basel) 2022; 10:healthcare10020253. [PMID: 35206869 PMCID: PMC8871881 DOI: 10.3390/healthcare10020253] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Revised: 01/24/2022] [Accepted: 01/26/2022] [Indexed: 02/01/2023] Open
Abstract
To date, no disease-specific tool has been available to assess the impact of chronic rhinosinusitis with nasal polyps (CRSwNP) on health-related quality of life (HRQoL). Therefore, the purpose of this study was to develop and validate a questionnaire specifically designed to this aim: the Nasal Polyposis Quality of Life (NPQ) questionnaire. As indicated in the current guidelines, the development and validation of the NPQ occurred in two separate steps involving different groups of patients. The questionnaire was validated by assessing internal structure, consistency, and validity. Responsiveness and sensitivity to changes were also evaluated. In the development process of NPQ an initial list of 40 items was given to 60 patients with CRSwNP; the 27 most significant items were selected and converted into questions. The validation procedure involved 107 patients (mean age 52.9 ± 12.4). NPQ revealed a five-dimensional structure and high levels of internal consistency (Cronbach’s alpha 0.95). Convergent validity (Spearman’ coefficient r = 0.75; p < 0.01), discriminant validity (sensitivity to VAS score), and reliability in a sample of patients with a stable health status (Interclass Coefficient 0.882) were satisfactory. Responsiveness to clinical changes was accomplished. The minimal important difference was 7. NPQ is the first questionnaire for the assessment of HRQoL in CRSwNP. Our results demonstrate that the new tool is valid, reliable, and sensitive to individual changes.
Collapse
Affiliation(s)
- Ilaria Baiardini
- Personalized Medicine Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (I.B.); (F.P.); (F.R.); (G.M.); (S.F.); (G.W.C.); (E.H.)
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20089 Milan, Italy; (A.M.); (G.S.); (G.M.); (G.M.)
| | - Giovanni Paoletti
- Personalized Medicine Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (I.B.); (F.P.); (F.R.); (G.M.); (S.F.); (G.W.C.); (E.H.)
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20089 Milan, Italy; (A.M.); (G.S.); (G.M.); (G.M.)
- Correspondence: ; Tel.: +39-02-2440-1821; Fax: +39-02-3440-6684
| | - Alessia Mariani
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20089 Milan, Italy; (A.M.); (G.S.); (G.M.); (G.M.)
| | - Luca Malvezzi
- Otorhinolaryngology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (L.M.); (F.P.)
| | - Francesca Pirola
- Otorhinolaryngology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (L.M.); (F.P.)
| | - Giuseppe Spriano
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20089 Milan, Italy; (A.M.); (G.S.); (G.M.); (G.M.)
- Otorhinolaryngology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (L.M.); (F.P.)
| | - Giuseppe Mercante
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20089 Milan, Italy; (A.M.); (G.S.); (G.M.); (G.M.)
- Otorhinolaryngology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (L.M.); (F.P.)
| | - Francesca Puggioni
- Personalized Medicine Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (I.B.); (F.P.); (F.R.); (G.M.); (S.F.); (G.W.C.); (E.H.)
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20089 Milan, Italy; (A.M.); (G.S.); (G.M.); (G.M.)
| | - Francesca Racca
- Personalized Medicine Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (I.B.); (F.P.); (F.R.); (G.M.); (S.F.); (G.W.C.); (E.H.)
| | - Giulio Melone
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20089 Milan, Italy; (A.M.); (G.S.); (G.M.); (G.M.)
| | - Giacomo Malipiero
- Personalized Medicine Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (I.B.); (F.P.); (F.R.); (G.M.); (S.F.); (G.W.C.); (E.H.)
| | - Sebastian Ferri
- Personalized Medicine Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (I.B.); (F.P.); (F.R.); (G.M.); (S.F.); (G.W.C.); (E.H.)
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20089 Milan, Italy; (A.M.); (G.S.); (G.M.); (G.M.)
| | - Giorgio Walter Canonica
- Personalized Medicine Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (I.B.); (F.P.); (F.R.); (G.M.); (S.F.); (G.W.C.); (E.H.)
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20089 Milan, Italy; (A.M.); (G.S.); (G.M.); (G.M.)
| | - Enrico Heffler
- Personalized Medicine Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089 Milan, Italy; (I.B.); (F.P.); (F.R.); (G.M.); (S.F.); (G.W.C.); (E.H.)
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20089 Milan, Italy; (A.M.); (G.S.); (G.M.); (G.M.)
| |
Collapse
|